Product Code: ETC13406686 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Human Milk Oligosaccharides Market was valued at USD 0.5 Billion in 2024 and is expected to reach USD 0.8 Billion by 2031, growing at a compound annual growth rate of 6.70% during the forecast period (2025-2031).
The Global Human Milk Oligosaccharides (HMO) Market is experiencing significant growth due to the rising awareness about the health benefits of HMOs in infant nutrition. HMOs are complex sugars naturally found in breast milk, and they play a crucial role in supporting infant gut health, immune function, and cognitive development. The market is driven by increasing demand for infant formula products fortified with HMOs as a way to mimic the nutritional composition of breast milk. Key market players are investing in research and development activities to introduce innovative HMO products and expand their market presence. Growing consumer preference for natural and organic ingredients in infant nutrition is also fueling market growth. The Global Human Milk Oligosaccharides Market is expected to continue its upward trajectory in the coming years as more parents seek optimal nutrition for their infants.
The Global Human Milk Oligosaccharides (HMO) market is experiencing significant growth due to the rising awareness of the health benefits associated with HMO consumption, particularly for infants. Increased research highlighting the role of HMO in promoting healthy gut microbiota and immune system development is driving market expansion. Manufacturers are focusing on developing innovative products with specific HMO compositions to cater to different age groups and health needs. Opportunities lie in expanding product offerings beyond infant formula to dietary supplements and functional foods targeting adults. Additionally, collaborations between industry players and research institutions to further explore the potential health benefits of HMO are expected to drive market growth in the coming years.
One of the key challenges faced in the Global Human Milk Oligosaccharides (HMO) Market is the high production costs associated with the extraction and purification of HMO. The complex process of isolating HMO from human milk, coupled with the limited availability of human milk donors, results in higher production expenses, which can impact the overall affordability of HMO-based products. Additionally, regulatory hurdles and the need for extensive research to better understand the health benefits and applications of HMO pose challenges for market expansion. Competition from alternative prebiotics and synthetic HMO substitutes further complicates market dynamics. Overcoming these obstacles will require advancements in technology, increased collaboration between stakeholders, and efforts to educate consumers on the value of HMO in promoting infant health and development.
The Global Human Milk Oligosaccharides Market is primarily being driven by the increasing awareness among consumers regarding the health benefits of human milk oligosaccharides (HMOs) for infant nutrition. With rising concerns over infant health and development, there is a growing demand for products enriched with HMOs as they are known to support the immune system, gut health, and cognitive development in infants. Additionally, the rising prevalence of breastfeeding challenges and the increasing adoption of infant formula fortified with HMOs by mothers who are unable to breastfeed are further propelling market growth. The research and development activities focused on enhancing the functionality and bioavailability of HMOs in infant formula products are also contributing to the expansion of the Global Human Milk Oligosaccharides Market.
Government policies related to the Global Human Milk Oligosaccharides Market vary across different countries. In the United States, regulatory bodies such as the Food and Drug Administration (FDA) oversee the safety and labeling of human milk oligosaccharides (HMOs) used in infant formula. The FDA requires manufacturers to provide scientific evidence demonstrating the safety and efficacy of these ingredients before they can be incorporated into products. In Europe, the European Food Safety Authority (EFSA) evaluates the safety and nutritional value of HMOs and sets maximum levels for their use in food products. Additionally, some countries provide subsidies or incentives to promote breastfeeding and the use of HMOs in infant nutrition. Overall, government policies aim to ensure the safety, quality, and proper labeling of HMO products in the market.
The Global Human Milk Oligosaccharides (HMO) market is poised for significant growth in the coming years, driven by increasing awareness of the health benefits associated with HMO consumption. HMOs are prebiotic compounds naturally found in breast milk, known for their ability to support gut health and boost immunity in infants. With the rising demand for natural and functional food ingredients, the market for HMOs is expected to expand as manufacturers incorporate these bioactive compounds into a wide range of products, including infant formula, dairy products, and dietary supplements. Additionally, ongoing research into the potential therapeutic applications of HMOs for addressing various health conditions is likely to further fuel market growth. Overall, the Global HMO market is forecasted to experience robust growth in the foreseeable future.
In the global human milk oligosaccharides market, Asia is expected to witness significant growth due to the rising awareness about the benefits of human milk oligosaccharides in infant nutrition. North America is projected to dominate the market, driven by the presence of key market players and increasing research and development activities in the region. Europe is anticipated to show steady growth, supported by the growing demand for infant formula enriched with human milk oligosaccharides. The Middle East and Africa region is likely to experience moderate growth, owing to the increasing adoption of premium infant nutrition products. Latin America is also expected to register a notable growth rate, fueled by the rising disposable income and changing dietary patterns in the region. However, regulatory challenges and limited awareness about human milk oligosaccharides may hinder market growth in some regions.
Global Human Milk Oligosaccharides (HMO) Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Human Milk Oligosaccharides (HMO) Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 & 2031F |
3.3 Global Human Milk Oligosaccharides (HMO) Market - Industry Life Cycle |
3.4 Global Human Milk Oligosaccharides (HMO) Market - Porter's Five Forces |
3.5 Global Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Concentration, 2021 & 2031F |
4 Global Human Milk Oligosaccharides (HMO) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Human Milk Oligosaccharides (HMO) Market Trends |
6 Global Human Milk Oligosaccharides (HMO) Market, 2021 - 2031 |
6.1 Global Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By 2' Fl, 2021 - 2031 |
6.1.3 Global Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By 3' Fl, 2021 - 2031 |
6.1.4 Global Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By 3' Sl, 2021 - 2031 |
6.1.5 Global Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By 6' Sl, 2021 - 2031 |
6.2 Global Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Infant Formula, 2021 - 2031 |
6.2.3 Global Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Functional Food & Beverages, 2021 - 2031 |
6.2.4 Global Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Food Supplement, 2021 - 2031 |
6.3 Global Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Concentration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Neutral, 2021 - 2031 |
6.3.3 Global Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Acidic, 2021 - 2031 |
7 North America Human Milk Oligosaccharides (HMO) Market, Overview & Analysis |
7.1 North America Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 - 2031 |
7.2 North America Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Concentration, 2021 - 2031 |
8 Latin America (LATAM) Human Milk Oligosaccharides (HMO) Market, Overview & Analysis |
8.1 Latin America (LATAM) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Concentration, 2021 - 2031 |
9 Asia Human Milk Oligosaccharides (HMO) Market, Overview & Analysis |
9.1 Asia Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Concentration, 2021 - 2031 |
10 Africa Human Milk Oligosaccharides (HMO) Market, Overview & Analysis |
10.1 Africa Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Concentration, 2021 - 2031 |
11 Europe Human Milk Oligosaccharides (HMO) Market, Overview & Analysis |
11.1 Europe Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Concentration, 2021 - 2031 |
12 Middle East Human Milk Oligosaccharides (HMO) Market, Overview & Analysis |
12.1 Middle East Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Human Milk Oligosaccharides (HMO) Market, Revenues & Volume, By Concentration, 2021 - 2031 |
13 Global Human Milk Oligosaccharides (HMO) Market Key Performance Indicators |
14 Global Human Milk Oligosaccharides (HMO) Market - Export/Import By Countries Assessment |
15 Global Human Milk Oligosaccharides (HMO) Market - Opportunity Assessment |
15.1 Global Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Concentration, 2021 & 2031F |
16 Global Human Milk Oligosaccharides (HMO) Market - Competitive Landscape |
16.1 Global Human Milk Oligosaccharides (HMO) Market Revenue Share, By Companies, 2024 |
16.2 Global Human Milk Oligosaccharides (HMO) Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |